EPIDEMIOLOGY

Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial

S R Dalziel¹, H H Rea³, N K Walker¹, V Parag¹, C Mantell⁴, A Rodgers¹, J E Harding²

¹ Clinical Trials Research Unit, The University of Auckland, Auckland, New Zealand
² Liggins Institute, The University of Auckland, Auckland, New Zealand
³ Department of Medicine, The University of Auckland, Auckland, New Zealand
⁴ Division of Maori and Pacific Health, The University of Auckland, Auckland, New Zealand

Correspondence to:
Professor J E Harding
Liggins Institute, The University of Auckland, Private Bag 92019, Auckland, New Zealand;j.harding{at}auckland.ac.nz

Background: Antenatal betamethasone is routinely used for the prevention of neonatal respiratory distress syndrome in preterm infants. However, little is known of the long term effects of exposure to antenatal betamethasone on lung function in adulthood.

Methods: Five hundred and thirty four 30 year olds whose mothers had participated in the first and largest randomised controlled trial of antenatal betamethasone were followed. Lung function was assessed by portable spirometric testing. The prevalence of asthma symptoms was assessed using the European Community Respiratory Health Survey questionnaire.

Results: Fifty (20%) betamethasone exposed and 53 (19%) placebo exposed participants met the criteria for current asthma (relative risk 0.98 (95% CI 0.74 to 1.30), p = 0.89). 181 betamethasone exposed and 202 placebo exposed participants had acceptable spirometric data. There were no differences in lung function between betamethasone and placebo exposed groups (mean (SD) forced vital capacity in the betamethasone and placebo groups 105.9 (12.0) v 106.6 (12.6)% predicted, difference = –0.7 (95% CI –3.2 to 1.8), p = 0.59; mean (SD) forced expiratory volume in 1 second in the betamethasone and placebo groups 98.9 (13.4) v 98.5 (13.6)% predicted, difference = 0.3 (95% CI –2.4 to 3.1, p = 0.80)).

Conclusions: Antenatal exposure to a single course of betamethasone does not alter lung function or the prevalence of wheeze and asthma at age 30.

Abbreviations: FEV₁, forced expiratory volume in 1 second; FVC, forced vital capacity; PEF, peak expiratory flow; RDS, respiratory distress syndrome

Keywords: neonatal respiratory distress syndrome; antenatal glucocorticoids; betamethasone; lung function; asthma

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Joseph, K. S., Nette, F., Scott, H., Vincer, M. J. (2009). Prenatal Corticosteroid Prophylaxis for Women Delivering at Late Preterm Gestation. Pediatrics 124: e835-e843 [Abstract] [Full Text]  
• Morrison, J. L., Orgeig, S. (2009). Review: Antenatal Glucocorticoid Treatment of The Growth-restricted Fetus: Benefit or Cost?. Reproductive Sciences 16: 527-538 [Abstract]  
• Narang, I., Rosenthal, M., Cremonesini, D., Silverman, M., Bush, A. (2008). Longitudinal Evaluation of Airway Function 21 Years after Preterm Birth. Am. J. Respir. Crit. Care Med. 178: 74-80 [Abstract] [Full Text]